NCT Number: NCT04787744
Phase: Phase 2|Phase 3
Trial Summary: The primary goal of this study is to determine if adding PET-directed local therapy improves disease control compared to standard systemic therapy alone in Veterans with oligorecur – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): VA Office of Research and Development
Acronym: VA STARPORT
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives